The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications.

M Goerner; H Wandt; Kerstin Schäfer-Eckart; Josef Birkmann; Theo Denzel; W M Gallmeier

The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications.

M Goerner, H Wandt, Kerstin Schäfer-Eckart (Co-author), Josef Birkmann (Co-author), Theo Denzel (Co-author), W M Gallmeier

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

6 Citations (Web of Science)

Original language	English
Pages (from-to)	387-391
Journal	JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
Volume	8
Issue number	4
Publication status	Published - 1999

Keywords

BONE-MARROW SUPPORT
TRANSPLANTATION
CELLS
ENGRAFTMENT
RELAPSE

Cite this

Goerner, M., Wandt, H., Schäfer-Eckart, K., Birkmann, J., Denzel, T., & Gallmeier, W. M. (1999). The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications. JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH , 8(4), 387-391.

Goerner, M ; Wandt, H ; Schäfer-Eckart, Kerstin et al. / The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications. In: JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH 1999 ; Vol. 8, No. 4. pp. 387-391.

@article{c6c603ef4b274843b6d486608d63abef,

title = "The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications.",

keywords = "BONE-MARROW SUPPORT, TRANSPLANTATION, CELLS, ENGRAFTMENT, RELAPSE",

author = "M Goerner and H Wandt and Kerstin Sch{\"a}fer-Eckart and Josef Birkmann and Theo Denzel and Gallmeier, {W M}",

year = "1999",

language = "English",

volume = "8",

pages = "387--391",

journal = "JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH ",

issn = "1525-8165",

number = "4",

}

Goerner, M, Wandt, H, Schäfer-Eckart, K, Birkmann, J, Denzel, T & Gallmeier, WM 1999, 'The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications.', JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH , vol. 8, no. 4, pp. 387-391.

The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications. / Goerner, M; Wandt, H; Schäfer-Eckart, Kerstin (Co-author) et al.
In: JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH , Vol. 8, No. 4, 1999, p. 387-391.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications.

AU - Goerner, M

AU - Wandt, H

AU - Schäfer-Eckart, Kerstin

AU - Birkmann, Josef

AU - Denzel, Theo

AU - Gallmeier, W M

PY - 1999

Y1 - 1999

KW - BONE-MARROW SUPPORT

KW - TRANSPLANTATION

KW - CELLS

KW - ENGRAFTMENT

KW - RELAPSE

M3 - Original Article

C2 - 10634176

SN - 1525-8165

VL - 8

SP - 387

EP - 391

JO - JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH

JF - JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH

IS - 4

ER -

Goerner M, Wandt H, Schäfer-Eckart K, Birkmann J, Denzel T, Gallmeier WM. The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications. JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH . 1999;8(4):387-391.